Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-09 Purchase |
2023-06-21 10:57 am |
Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner |
180,555 | $0.6 | $108,333 | 1,876,127 (Indirect Direct) |
View |
| 2021-03-26 Purchase |
2021-12-13 4:30 pm |
Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner |
135,560 | $0 | $0 | 1,479,450 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-13 Conversion |
2023-06-21 10:59 am |
N/A N/A |
Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner |
3,102,878 | $0.6 | 4,979,005 (Indirect) |
View |
| 2022-03-31 Conversion |
2022-06-21 5:47 pm |
N/A N/A |
Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner |
77,887 | $9.5 | 1,678,096 (Indirect) |
View |
| 2021-07-15 Exercise |
2021-12-13 4:32 pm |
2020-07-26 2026-07-26 |
Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner |
120,759 | $0 | 1,661,465 (Direct) |
View |
| 2021-03-29 Option Award |
2021-12-13 4:31 pm |
N/A N/A |
Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner |
61,256 | $0 | 1,540,706 (Indirect) |
View |